<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04372251</url>
  </required_header>
  <id_info>
    <org_study_id>20/00912</org_study_id>
    <nct_id>NCT04372251</nct_id>
  </id_info>
  <brief_title>Osteosynthesis of Intraarticular Calcaneal Fractures: Arthroscopically Assisted Percutaneous Technique Versus Sinus Tarsi Approach</brief_title>
  <official_title>Osteosynthesis of Intraarticular Calcaneal Fractures: Arthroscopically Assisted Percutaneous Technique Versus Sinus Tarsi Approach - A Randomized Controlled Multicenter Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ostfold Hospital Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vestre Viken Hospital Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ostfold Hospital Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this randomized controlled trial, the outcomes of two surgical techniques for&#xD;
      intraarticular calcaneal fractures will be evaluated and compared.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Operative treatment of calcaneal features through an extensile lateral approach (ELA) has&#xD;
      been the gold standard over many years despite high rates of infection and soft tissue&#xD;
      complications.&#xD;
&#xD;
      Lately, there has been a trend towards less invasive fixation methods. Minimally invasive&#xD;
      plate osteosynthesis using the sinus tarsi approach (STA) has gained popularity during the&#xD;
      last decade.&#xD;
&#xD;
      Furthermore, percutaneous reduction and fixation techniques have been described and used for&#xD;
      a few decades. In the early 2000s, Rammelt et al. were the first who introduced a&#xD;
      percutaneous technique assisted by hindfoot arthroscopy. The percutaneous and&#xD;
      arthroscopically assisted calcaneal osteosynthesis (PACO) is applicable in Sanders II and III&#xD;
      fractures and has been shown to provide good clinical outcomes as well as a low rate of&#xD;
      complications.&#xD;
&#xD;
      The study is designed as a superiority study. Our hypothesis is that the percutaneous and&#xD;
      arthroscopically assisted technique provides superior outcomes compared to the sinus tarsi&#xD;
      approach in Sanders II and III calcaneal fractures.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 5, 2020</start_date>
  <completion_date type="Anticipated">December 2031</completion_date>
  <primary_completion_date type="Anticipated">December 2030</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Two-arm parallel assignment. Patients er randomized to operative treatment with either the sinus tarsi approach or percutaneous and arthroscopically assisted osteosynthesis.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>The investigators that will conduct the follow-up examinations 2 and 5 years after surgery will be blinded for the operative treatment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Manchester-Oxford Foot Questionnaire (MOxFQ)</measure>
    <time_frame>5 years</time_frame>
    <description>Foot-Ankle specific PROM (0-100 with 0 representing the best possible outcome)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot score</measure>
    <time_frame>5 years</time_frame>
    <description>Widely used foot/ankle score (0-100 with 100 representing the best possible outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calcaneus Fracture Scoring System (CFSS)</measure>
    <time_frame>5 years</time_frame>
    <description>Calcaneal fracture specific scoring system (0-100 with 100 representing the best possible outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported foot and ankle score (SEFAS)</measure>
    <time_frame>5 years</time_frame>
    <description>Foot-Ankle specific PROM (0-48 with 48 representing the best possible outcome)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale (VAS) for pain</measure>
    <time_frame>5 years</time_frame>
    <description>Scores pain at rest and on activity (0-10 with 0 representing no pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of complications</measure>
    <time_frame>5 years</time_frame>
    <description>Yes/no for deep or superficial infection, nerve or tendon injury, deep venous thrombosis, hardware complaints and secondary surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Böhler angle</measure>
    <time_frame>5 years</time_frame>
    <description>Böhler angle pre- and post surgery as well as at follow up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subtalar osteoarthritis</measure>
    <time_frame>5 years</time_frame>
    <description>The presence of subtalar osteoarthritis is graded based on the Brodén radiographs taken at 1 year, 2 year and 5 year follow-up using the Kellgren &amp; Lawrence classification system.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Calcaneus Fracture</condition>
  <arm_group>
    <arm_group_label>Sinus tarsi approach (STA)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to this arm are operated with plate osteosynthesis via the sinus tarsi approach</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Percutaneous Arthroscopically Assisted Osteosynthesis (PACO)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients randomized to this arm are operated with percutaneous reduction of the fracture and osteosynthesis with screws, assisted by subtalar arthroscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sinus tarsi approach (STA)</intervention_name>
    <description>Osteosynthesis</description>
    <arm_group_label>Sinus tarsi approach (STA)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous Arthroscopically Assisted Osteosynthesis (PACO)</intervention_name>
    <description>Osteosynthesis</description>
    <arm_group_label>Percutaneous Arthroscopically Assisted Osteosynthesis (PACO)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Dislocated intraarticular calcaneal fracture, type Sanders II or Sanders III with an&#xD;
             intraarticular step &gt; 2mm&#xD;
&#xD;
          -  Patients between 18 and 70 years of age&#xD;
&#xD;
          -  Acute presentation at one of our departments, enabling surgery within 10 days after&#xD;
             injury&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Intraarticular step of &lt; 2mm&#xD;
&#xD;
          -  Sanders IV fractures&#xD;
&#xD;
          -  Open fractures&#xD;
&#xD;
          -  Bilateral injuries&#xD;
&#xD;
          -  Concomitant major injuries of the foot, ankle or leg that affect the rehabilitation&#xD;
             process&#xD;
&#xD;
          -  Multitraumized patients&#xD;
&#xD;
          -  Previous injury or surgery of the hindfoot&#xD;
&#xD;
          -  Charcot foot&#xD;
&#xD;
          -  Serious medical condition that contradicts surgery&#xD;
&#xD;
          -  Noncompliant patients&#xD;
&#xD;
          -  Insufficient Norwegian or English language skills&#xD;
&#xD;
          -  Patients not available for follow-up&#xD;
&#xD;
          -  Inability to conduct the rehabilitation protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Are Stødle, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Frede Frihagen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ostfold Hospital Trust</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wolfram Grün, MD</last_name>
    <phone>+4741297874</phone>
    <email>wolframgruen@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marius Molund, MD, PhD</last_name>
    <phone>+4790093988</phone>
    <email>mariusmolund@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gard Kristian Anderssen, MD</last_name>
      <email>gard.kristian.anderssen@helse-bergen.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vestre Viken Hospital Trust - Drammen hospital</name>
      <address>
        <city>Drammen</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erik Bjørbæk, MD</last_name>
      <email>B30957@vestreviken.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oslo university hospial</name>
      <address>
        <city>Oslo</city>
        <zip>0588</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfram Grün, MD</last_name>
      <phone>+4741297874</phone>
      <email>wolframgruen@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Are Stødle, MD</last_name>
      <phone>+4797174507</phone>
      <email>arhauk@ous-hf.no</email>
    </contact_backup>
    <investigator>
      <last_name>Elisabeth Ellingsen Husebye, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vestre Viken Hospital Trust - Bærum hospital</name>
      <address>
        <city>Sandvika</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Espen Laudal, MD</last_name>
      <email>eslaud@vestreviken.no</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Østfold Hospital Trust</name>
      <address>
        <city>Sarpsborg</city>
        <state>Østfold</state>
        <zip>1714</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marius Molund, MD, PhD</last_name>
      <phone>+4790093988</phone>
      <email>marius.molund@so-hf.no</email>
    </contact>
    <contact_backup>
      <last_name>Fredrik Nilsen, MD</last_name>
      <email>fredni@so-hf.no</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 29, 2020</study_first_submitted>
  <study_first_submitted_qc>April 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2020</study_first_posted>
  <last_update_submitted>May 20, 2021</last_update_submitted>
  <last_update_submitted_qc>May 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Calcaneal fracture</keyword>
  <keyword>Subtalar arthroscopy</keyword>
  <keyword>Trauma</keyword>
  <keyword>Calcaneus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

